Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medifast Inc. (MED:NYSE), powered by AI.
Medifast Inc. is currently trading at $9.64. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medifast Inc. on Alpha Lenz.
Medifast Inc.'s P/E ratio is -5.7.
“Medifast Inc. trades at a P/E of -5.7 (undervalued) with modest ROE of -9.1%.”
Ask for details →Medifast Inc. is a prominent player in the health and wellness industry, focused on providing scientifically developed weight management and healthy living products. With a range of offerings that include meal replacement products, snacks, and hydration solutions, the company caters to individuals seeking sustainable lifestyle transformations. Medifast reaches its customers primarily through its OPTAVIA Coaches, an integral part of their direct selling model, which offers personalized support and guidance. This unique network not only enhances customer engagement but also strengthens community-driven success. The company's innovative approach in combining nutritional science with one-on-one coaching sets it apart in the highly competitive health sector. Medifast's targeted solutions and emphasis on educational support play a significant role in the wellness revolution. As consumer interest in health-related products continues to rise, Medifast's strategies ensure its relevance and adaptability in a dynamic market, positioning it as a significant contributor to health and wellness industries globally.
“Medifast Inc. trades at a P/E of -5.7 (undervalued) with modest ROE of -9.1%.”
Ask for details →Medifast Inc. (ticker: MED) is a company listed on NYSE in the Consumer Cyclical sector (Personal Services). It has approximately 504 employees. Market cap is $106M.
The current price is $9.64 with a P/E ratio of -5.67x and P/B of 0.53x.
ROE is -9.13% and operating margin is -3.68%. Annual revenue is $386M.